Documentation scienceplus.abes.fr version Bêta
AttributsValeurs
type
Is Part Of
Subject
Title
  • Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductions
has manifestation of work
related by
Abstract
  • Commentary on: DjulbegovicMBeythRJNeubergerMM. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ2010;341:c4543.
article type
publisher identifier
  • ebmed1165
is part of this journal
PubMed ID
  • 21228057



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata